Fiber Therapy Calcium polycarbophil 625 mg Tablet, 140-count
by Wal-Mart Stores, Inc. · 140 TABLET in 1 BOTTLE (49035-147-94)
NDC 49035-0147-94
🏷️ FDA NDC (as labeled)
49035-147-94
billing pads the product segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
49035-147-94
Product NDC
49035-147
11-digit billing NDC
49035014794
NCPDP billing unit
EA — each (per item)
RxCUI
308934
UNII
8F049NKY49
Application #
M007
SPL Set ID
3432a4a6-aeb1-4a72-8451-5903266931fa
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2013-11-01
Route
ORAL
Dosage form
TABLET
Substance
CALCIUM POLYCARBOPHIL
GPI-14
46300020100310
GPI class
EQ Fiber Therapy
GCN Seq No
003065
GCN
08342
HICL code
001346
Ingredient (HICL)
Calcium Polycarbophil
HIC1 code
D
Therapeutic class — broad (HIC1)
Biliary System/Gastro-Intestinal System
HIC2 code
D6
Therapeutic class — intermediate (HIC2)
Drugs Acting Principally On The Colon
HIC3 code
D6S
Therapeutic class — specific (HIC3)
Laxatives And Cathartics
AHFS code
56:12.00.00
AHFS class
Cathartics And Laxatives
FDB label name
EQ FIBER THERAPY 625 MG CAPLET
FDB brand name
Fiber Therapy
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 49035-147-94 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 49035-0147-94. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Bulk-forming laxatives class.
Drug family (ATC)
Bulk-forming laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerWal-Mart Stores, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code49035
First marketedNov 2013
Product typeHuman Otc Drug
Portfolio83 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name EQ FIBER THERAPY 625 MG CAPLET Ingredient Calcium Polycarbophil
🧪 What is this product?
Fiber Therapy is an over-the-counter oral tablet containing calcium polycarbophil, a bulk-forming laxative. Calcium polycarbophil is typically used to help relieve occasional constipation and to promote normal bowel regularity. This product is marketed under FDA's over-the-counter monograph rules for laxatives and is not the result of an individual drug application review. The active ingredient works by absorbing water in the intestines to help increase stool bulk and ease bowel movements.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Calcium Polycarbophil — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Calcium polycarbophil?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
White
ShapeCapsule
ImprintG147
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII H0G9379FGK
Calcium carbonate is a white mineral powder used as a filler and buffering agent in medicines. It helps give tablets their bulk and size while neutralizing stomach acid in some formulations.
-
UNII T9D99G2B1R
Caramel is a brown coloring substance made by heating sugar. It's added to medicines to give them color and sometimes a slight sweet taste without affecting how the drug works.
-
UNII 2S7830E561
Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
-
UNII 3NXW29V3WO
Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII 3WJQ0SDW1A
Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 368GB5141J
A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
9 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statescalcium carbonate, caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Fiber Lax 625 mg 00536-4306-05 | Rugby | 500 tablets | $0.058 | — | Availability likely | — |
| Fiber Tabs 625 mg 00904-2500-91 | Major | 90 tablets | $0.058 | — | Availability likely | — |
| Calcium Polycarbophil 625 mg 70000-0067-01 | LEADER/ | 250 tablets | $0.058 | — | Availability likely | — |
| Foster and Thrive Fiber Laxative 147 625 mg 70677-1083-01 | Strategic | 90 tablets | $0.058 | — | Availability likely | — |
| Fiber caplets 147 625 mg 83324-0131-90 | Chain | 90 tablets | $0.058 | — | Availability likely | — |
| Walgreen Fiber Lax 625 mg 00363-0120-14 | WALGREENS | 140 tablets | — | — | FDA listed | — |
| up and up fiber therapy 625 mg 11673-0620-90 | Target | 140 tablets | — | — | FDA listed | — |
| Rite Aid Fiber Caplets 625 mg 11822-2025-00 | RITE | 250 tablets | — | — | FDA listed | — |
| Fiber Caplets 625 mg 21130-0021-40 | SAFEWAY | 140 tablets | — | — | FDA listed | — |
| Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free 625 mg 24385-0125-27 | Amerisourcebergen | 90 capsules | — | — | FDA listed | — |
| Fiber Caplets 625 mg 30142-0132-14 | THE | 140 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 36800-0465-27 | Topco | 90 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 41163-0147-94 | UNITED | 140 tablets | — | — | FDA listed | — |
| Publix 625 mg 41415-0021-90 | PUBLIX | 90 tablets | — | — | FDA listed | — |
| Fiber Therapy 625 mgthis 49035-0147-94 | Wal-Mart | 140 tablets | — | — | FDA listed | — |
| Goodsense Fiber laxative 147 625 mg 50804-0147-94 | GoodSense | 140 tablets | — | — | FDA listed | — |
| Fiber Caps 625 mg 53041-0147-27 | Guardian | 90 tablets | — | — | FDA listed | — |
| Fiber laxative 625 mg 53943-0147-27 | Discount | 90 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 54257-0379-07 | Magno-Humphries, | 90 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 54257-0479-07 | Magno-Humphries, | 90 tablets | — | — | FDA listed | — |
| Fiber Lax 625 mg 55289-0949-30 | PD-Rx | 30 tablets | — | — | FDA listed | — |
| Fiber Laxative 625 mg 57896-0459-09 | Geri-Care | 90 tablets | — | — | FDA listed | — |
| Calcium Polycarbophil 625 mg 58624-5003-01 | SHANDONG | 90 tablets | — | — | FDA listed | — |
| Quality Choice 625 mg 63868-0530-90 | QUALITY | 90 tablets | — | — | FDA listed | — |
| Best Choice 625 mg 63941-0023-90 | BEST | 90 tablets | — | — | FDA listed | — |
| Premier Value 625 mg 68016-0220-25 | PHARMACY | 250 tablets | — | — | FDA listed | — |
| Calcium Polycarbophil 625 mg 69842-0846-02 | CVS | 250 tablets | — | — | FDA listed | — |
| Calcium Polycarbophil 625 mg 70369-0006-08 | CITRAGEN | 120 tablets | — | — | FDA listed | — |
| Amazon Fiber Caplets 625 mg 72288-0201-40 | AMAZON.COM | 140 tablets | — | — | FDA listed | — |
| Fiber Laxative Caplets 625 mg 77333-0120-50 | Gendose | 50 tablets | — | — | FDA listed | — |
| Meijer Fiber Caplets 625 mg 79481-1205-00 | MEIJER | 250 tablets | — | — | FDA listed | — |
| Fibercon 625 mg 80070-0500-14 | Foundation | 140 tablets | — | — | FDA listed | — |
| Quality Choice Fiber Caplets 625 mg 83324-0276-14 | QUALITY | 140 tablets | — | — | FDA listed | — |
| Equalactin Laxative 625 mg 69846-0000-26 | NUMARK | 24 tablets | — | — | Discontinued | — |
| Fibercon 625 mg 63029-0170-14 | Medtech | 140 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2013
On the market since
Nov 2013
📍
2026
Currently FDA-listed
13 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for FIBER THERAPY (this brand).
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 49035-0147-94 You're viewing this | 140 TABLET in 1 BOTTLE (49035-147-94) | 2013-11-01 | Active |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 49035-147-94, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 49035-0147-94, written without dashes as 49035014794. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 49035-0147-94, the first segment (49035) is the labeler code FDA assigned to Wal-Mart Stores, Inc.; the middle segment (0147) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (94) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Wal-Mart Stores, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Wal-Mart Stores, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
USE(S) relieves occasional constipation this product generally produces bowel movement in 12 to 72 hours
⏱️ Dosage and Administration ▾
DIRECTIONS take this product (child or adult dose) with a full glass or water (8oz.) or other fluid. Taking this product without enough liquid may cause chocking. See choking warning. dosage will vary according to diet, exercise, previous laxative use or severity of constipation continued use for 1 to 3 days is normally required to provide full benefit adults and children 12 years and over 2 caplets, 1 to 4 times a day children under 12 years ask a doctor
⚠️ Warnings ▾
WARNINGS Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.
📦 Storage and Handling ▾
OTHER INFORMATION each caplet contains: calcium 135 mg do not use if printed seal under cap is torn or missing store at room temperature protect contents from moisture
🧪 Active Ingredient ▾
ACTIVE INGREDIENT (in each caplet) Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophil
🧪 Inactive Ingredients ▾
INACTIVE INGREDIENTS calcium carbonate, caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate.
🎯 Purpose ▾
PURPOSE Bulk-forming laxative
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.